Dr. Bardia Discusses Recent Advancements in the Field of Breast Cancer

Dr. Bardia Discusses Recent Advancements in the Field of Breast Cancer

Dr. Bardia on the Clinical Utility of Liquid Biopsies in Breast CancerПодробнее

Dr. Bardia on the Clinical Utility of Liquid Biopsies in Breast Cancer

Dr. Aditya Bardia | San Antonio Breast Cancer Symposium 2022 | General SessionПодробнее

Dr. Aditya Bardia | San Antonio Breast Cancer Symposium 2022 | General Session

Dr. Bardia on the Role of the Microenvironment in TNBCПодробнее

Dr. Bardia on the Role of the Microenvironment in TNBC

Ongoing Research: Advancements in Breast Cancer ManagementПодробнее

Ongoing Research: Advancements in Breast Cancer Management

Breast Cancer | Dr. Rakesh Neve | Manipal Hospital BanerПодробнее

Breast Cancer | Dr. Rakesh Neve | Manipal Hospital Baner

Dr. Bardia on Sacituzumab Govitecan in Triple-Negative Breast CancerПодробнее

Dr. Bardia on Sacituzumab Govitecan in Triple-Negative Breast Cancer

Breast Cancer Awareness- What are some recent advancements in the field of radiation oncology?Подробнее

Breast Cancer Awareness- What are some recent advancements in the field of radiation oncology?

Dr Bardia on Current Approaches to HER2+ Breast Cancer ManagementПодробнее

Dr Bardia on Current Approaches to HER2+ Breast Cancer Management

Dr. Bardia Describes the Snapshot Assay for Breast CancerПодробнее

Dr. Bardia Describes the Snapshot Assay for Breast Cancer

Dr. Aditya Bardia on RAD1901 in ER-Positive Metastatic Breast CancerПодробнее

Dr. Aditya Bardia on RAD1901 in ER-Positive Metastatic Breast Cancer

Dr. Jamie Wagner Discusses Advancements in Breast Cancer TreatmentПодробнее

Dr. Jamie Wagner Discusses Advancements in Breast Cancer Treatment

Metastatic breast cancer: promising therapeutic avenuesПодробнее

Metastatic breast cancer: promising therapeutic avenues

Dr Aditya Bardia Discusses the Advantages of Sacituzumab Govitecan for Triple-Negative Breast CancerПодробнее

Dr Aditya Bardia Discusses the Advantages of Sacituzumab Govitecan for Triple-Negative Breast Cancer

Dr. Bardia on Potential Concerns With Biosimilars in Breast CancerПодробнее

Dr. Bardia on Potential Concerns With Biosimilars in Breast Cancer

Dr. Kass Discusses HER2-Positive Breast Cancer AdvancementsПодробнее

Dr. Kass Discusses HER2-Positive Breast Cancer Advancements

New Strategies in Breast Cancer: Innovations In Clinical TrialsПодробнее

New Strategies in Breast Cancer: Innovations In Clinical Trials

Dr. Bardia on the Results of the ASCENT Trial in Previously Treated Metastatic TNBCПодробнее

Dr. Bardia on the Results of the ASCENT Trial in Previously Treated Metastatic TNBC

Drs. Bardia, Hurvitz, & Spring talk #BreastCancer during #ASCO22 - https://bit.ly/3tVN82XПодробнее

Drs. Bardia, Hurvitz, & Spring talk #BreastCancer during #ASCO22 - https://bit.ly/3tVN82X

Dr. Bardia on Dual Targeting of the HER2 ReceptorПодробнее

Dr. Bardia on Dual Targeting of the HER2 Receptor